Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial)

Charles D. Meyers, Madeline McCarren, Nathan D. Wong, Carlos Abraira, William C. Duckworth, Moti L. Kashyap

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The American Diabetes Association has established lipid goals for patients with diabetes. Although diabetic populations historically have poor low-density lipoprotein (LDL) cholesterol goal adherence, little is known about adherence to triglyceride and high-density lipoprotein (HDL) cholesterol goals. To determine the degree of lipid goal attainment among patients with diabetes, and to characterize the patterns of lipid medication use, we evaluated the baseline data from 1,742 enrollees of the national Veterans Affairs Diabetes Trial. Using current American Diabetes Association lipid guidelines, we calculated the proportion of participants achieving a LDL cholesterol level <100 mg/dl, triglyceride level <150 mg/dl, and HDL cholesterol level >40 mg/dl in men (>50 mg/dl in women). We also performed a descriptive analysis of the use of lipid medications in this population. The baseline LDL cholesterol level was 111 ± 63 mg/dl, triglyceride level was 213 ± 277 mg/dl, and HDL cholesterol was 36 ± 10 mg/dl. At enrollment, 44% of veterans met the LDL cholesterol goal, 58% met the triglyceride goal, and 16% met the HDL cholesterol goal, but only 6% met all 3 goals. Of the 1,742 enrollees, 2/3 were receiving lipid therapy, with statins (58%) the most commonly used drug. Combination lipid therapy was used by 11% of enrollees. Although the enrollees of the Veterans Affairs Diabetes Trial demonstrated better adherence to the American Diabetes Association's LDL cholesterol goal than other diabetic populations recently studied, more aggressive and directed lipid medication use is needed to treat the overall lipid profile better.

Original languageEnglish
Pages (from-to)63-65
Number of pages3
JournalAmerican Journal of Cardiology
Volume98
Issue number1
DOIs
StatePublished - Jul 1 2006

Fingerprint

Veterans
Diabetes Mellitus
Lipids
LDL Cholesterol
HDL Cholesterol
Triglycerides
Population
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Guidelines
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial). / Meyers, Charles D.; McCarren, Madeline; Wong, Nathan D.; Abraira, Carlos; Duckworth, William C.; Kashyap, Moti L.

In: American Journal of Cardiology, Vol. 98, No. 1, 01.07.2006, p. 63-65.

Research output: Contribution to journalArticle

Meyers, Charles D. ; McCarren, Madeline ; Wong, Nathan D. ; Abraira, Carlos ; Duckworth, William C. ; Kashyap, Moti L. / Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial). In: American Journal of Cardiology. 2006 ; Vol. 98, No. 1. pp. 63-65.
@article{26877b2db8244fd39029b2929b39c2d0,
title = "Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial)",
abstract = "The American Diabetes Association has established lipid goals for patients with diabetes. Although diabetic populations historically have poor low-density lipoprotein (LDL) cholesterol goal adherence, little is known about adherence to triglyceride and high-density lipoprotein (HDL) cholesterol goals. To determine the degree of lipid goal attainment among patients with diabetes, and to characterize the patterns of lipid medication use, we evaluated the baseline data from 1,742 enrollees of the national Veterans Affairs Diabetes Trial. Using current American Diabetes Association lipid guidelines, we calculated the proportion of participants achieving a LDL cholesterol level <100 mg/dl, triglyceride level <150 mg/dl, and HDL cholesterol level >40 mg/dl in men (>50 mg/dl in women). We also performed a descriptive analysis of the use of lipid medications in this population. The baseline LDL cholesterol level was 111 ± 63 mg/dl, triglyceride level was 213 ± 277 mg/dl, and HDL cholesterol was 36 ± 10 mg/dl. At enrollment, 44{\%} of veterans met the LDL cholesterol goal, 58{\%} met the triglyceride goal, and 16{\%} met the HDL cholesterol goal, but only 6{\%} met all 3 goals. Of the 1,742 enrollees, 2/3 were receiving lipid therapy, with statins (58{\%}) the most commonly used drug. Combination lipid therapy was used by 11{\%} of enrollees. Although the enrollees of the Veterans Affairs Diabetes Trial demonstrated better adherence to the American Diabetes Association's LDL cholesterol goal than other diabetic populations recently studied, more aggressive and directed lipid medication use is needed to treat the overall lipid profile better.",
author = "Meyers, {Charles D.} and Madeline McCarren and Wong, {Nathan D.} and Carlos Abraira and Duckworth, {William C.} and Kashyap, {Moti L.}",
year = "2006",
month = "7",
day = "1",
doi = "10.1016/j.amjcard.2006.01.061",
language = "English",
volume = "98",
pages = "63--65",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial)

AU - Meyers, Charles D.

AU - McCarren, Madeline

AU - Wong, Nathan D.

AU - Abraira, Carlos

AU - Duckworth, William C.

AU - Kashyap, Moti L.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - The American Diabetes Association has established lipid goals for patients with diabetes. Although diabetic populations historically have poor low-density lipoprotein (LDL) cholesterol goal adherence, little is known about adherence to triglyceride and high-density lipoprotein (HDL) cholesterol goals. To determine the degree of lipid goal attainment among patients with diabetes, and to characterize the patterns of lipid medication use, we evaluated the baseline data from 1,742 enrollees of the national Veterans Affairs Diabetes Trial. Using current American Diabetes Association lipid guidelines, we calculated the proportion of participants achieving a LDL cholesterol level <100 mg/dl, triglyceride level <150 mg/dl, and HDL cholesterol level >40 mg/dl in men (>50 mg/dl in women). We also performed a descriptive analysis of the use of lipid medications in this population. The baseline LDL cholesterol level was 111 ± 63 mg/dl, triglyceride level was 213 ± 277 mg/dl, and HDL cholesterol was 36 ± 10 mg/dl. At enrollment, 44% of veterans met the LDL cholesterol goal, 58% met the triglyceride goal, and 16% met the HDL cholesterol goal, but only 6% met all 3 goals. Of the 1,742 enrollees, 2/3 were receiving lipid therapy, with statins (58%) the most commonly used drug. Combination lipid therapy was used by 11% of enrollees. Although the enrollees of the Veterans Affairs Diabetes Trial demonstrated better adherence to the American Diabetes Association's LDL cholesterol goal than other diabetic populations recently studied, more aggressive and directed lipid medication use is needed to treat the overall lipid profile better.

AB - The American Diabetes Association has established lipid goals for patients with diabetes. Although diabetic populations historically have poor low-density lipoprotein (LDL) cholesterol goal adherence, little is known about adherence to triglyceride and high-density lipoprotein (HDL) cholesterol goals. To determine the degree of lipid goal attainment among patients with diabetes, and to characterize the patterns of lipid medication use, we evaluated the baseline data from 1,742 enrollees of the national Veterans Affairs Diabetes Trial. Using current American Diabetes Association lipid guidelines, we calculated the proportion of participants achieving a LDL cholesterol level <100 mg/dl, triglyceride level <150 mg/dl, and HDL cholesterol level >40 mg/dl in men (>50 mg/dl in women). We also performed a descriptive analysis of the use of lipid medications in this population. The baseline LDL cholesterol level was 111 ± 63 mg/dl, triglyceride level was 213 ± 277 mg/dl, and HDL cholesterol was 36 ± 10 mg/dl. At enrollment, 44% of veterans met the LDL cholesterol goal, 58% met the triglyceride goal, and 16% met the HDL cholesterol goal, but only 6% met all 3 goals. Of the 1,742 enrollees, 2/3 were receiving lipid therapy, with statins (58%) the most commonly used drug. Combination lipid therapy was used by 11% of enrollees. Although the enrollees of the Veterans Affairs Diabetes Trial demonstrated better adherence to the American Diabetes Association's LDL cholesterol goal than other diabetic populations recently studied, more aggressive and directed lipid medication use is needed to treat the overall lipid profile better.

UR - http://www.scopus.com/inward/record.url?scp=33745145442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745145442&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2006.01.061

DO - 10.1016/j.amjcard.2006.01.061

M3 - Article

VL - 98

SP - 63

EP - 65

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -